Aerovate Therapeutics, Inc.
AVTE
Revenue
0.00
0.000.00%
-Assets
111.69M
▲4.87M▲4.56%
3 Months ChangeLiabilities
17.30M
▲1.38M▲8.66%
3 Months ChangeFree Cash Flow
-11.44M
▼-5.75M▼-101.09%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001104659-24-112896
2024-10-17
Form 8-K
ID: 0001798749-24-000055
2024-10-10
Form 8-K
ID: 0001798749-24-000052
2024-08-12
Form 10-Q
ID: 0001798749-24-000049
2024-07-08
Form 8-K
ID: 0001798749-24-000042
2024-06-28
Form 8-K
ID: 0001798749-24-000036
2024-06-17
Form 8-K
ID: 0001104659-24-072058
2024-06-07
Form 8-K
ID: 0001798749-24-000033
2024-05-13
Form 10-Q
ID: 0001558370-24-007985
2024-05-13
Form 8-K
ID: 0001798749-24-000029